Intrinsic Value of S&P & Nasdaq Contact Us

Profound Medical Corp. PROF NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • CA • USD

SharesGrow Score
81/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.00
+86.9%

Profound Medical Corp. (PROF) reported total assets of $192.94M and total liabilities of $101.95M for quarter ending 2025-12-31, resulting in total equity of $90.99M.

The company held $81.8M in cash and short-term investments. Total debt stood at $6.45M, with net debt of $-75.34M. The Debt-to-Equity (D/E) ratio was 0.07 (conservative).

Current ratio is 12.52, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.07, current ratio of 12.52 — balance sheet is strong
  • MOAT (50/100) — Total assets $192.94M and equity $90.99M support the company's competitive scale
  • VALUE (100/100) — Debt-to-Equity 0.07 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 81/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
81/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
GROWTH
100/100
→ Income
INCOME
100/100
→ Income
Profound Medical Corp. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $192.94M$42.31M$49.67M$60.86M
Total Liabilities $101.95M$10.16M$10.41M$10.07M
Total Debt $6.45M$277K$4.81M$4.88M
Cash & Investments $81.8M$24.83M$35.2M$46.43M
Total Stockholders Equity $90.99M$32.14M$39.26M$50.79M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message